Decoy Therapeutics（DCOY.US）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

© 2026 Longbridge｜服務條款隱私政策

股東類型

公眾及其他98.73%
機構投資者0.80%
個人與內幕人士0.48%

主要股東

主要股東最新
股東
Vanguard Capital Management, LLC	0.76%	4,034.00	--	+4,034.00	30/06/2026
Vanguard Capital Management, LLC	0.62%	4,034.00	--	+4,034.00	30/06/2026
Mark RosenblumExecutive VP of Finance & CFO	0.32%	1,681.00	0.00%	+0	30/04/2026
Frederick PierceCEO & Director	0.26%	1,389.00	0.00%	+0	30/04/2026
Mark RosenblumExecutive VP of Finance & CFO	0.26%	1,681.00	0.06%	+0	30/04/2026
Frederick PierceCEO & Director	0.21%	1,389.00	0.05%	+0	30/04/2026
Geode Capital Management, LLC	0.17%	910.00	0.00%	+0	31/12/2025
Geode Capital Management, LLC	0.14%	910.00	0.03%	+0	31/12/2025
Tower Research Capital Europe Limited	0.05%	256.00	0.14%	-765.00	30/06/2026
Tower Research Capital Europe Limited	0.04%	256.00	0.15%	-765.00	30/06/2026
David ArthurFormer Director	<0.01%	34.00	0.00%	+0	30/04/2026
David ArthurFormer Director	<0.01%	34.00	<0.01%	+0	30/04/2026
UBS Asset Management AG	<0.01%	25.00	0.10%	-521.00	30/06/2026
UBS Asset Management AG	<0.01%	25.00	0.10%	-521.00	30/06/2026
Caitong International Asset Management Co., Limited	<0.01%	2.00	--	+2.00	30/06/2026
William McVicarIndependent Chairman of the Board	<0.01%	2.00	0.00%	+0	30/04/2026
Arnold HanishIndependent Director	<0.01%	2.00	0.08%	-415.00	30/04/2026
Jonathan LieberIndependent Director	<0.01%	2.00	0.00%	+0	30/04/2026
Teresa BurlesonIndependent Director	<0.01%	2.00	0.00%	+0	30/04/2026
Caitong International Asset Management Co., Limited	<0.01%	2.00	--	+2.00	30/06/2026